Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia.

Int J Nephrol Renovasc Dis · 2010 · PMC3108781 · PMID 21694922

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In spite of its superiority at lowering serum urate levels, febuxostat showed a trend, but no statistically significant superiority to allopurinol in preventing gout flares by 52 weeks.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.